You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
@@ -116,12 +150,12 @@ To release a new version, update the version number in `version.rb`, and then ru
116
150
## Contributing
117
151
118
152
Bug reports and pull requests are welcome on GitHub at https://github.com/hebron-george/open_fda_api .
119
-
This project is intended to be a safe, welcoming space for collaboration, and contributors are expected to adhere to the [code of conduct](https://github.com/[USERNAME]/open_fda_api/blob/master/CODE_OF_CONDUCT.md).
153
+
This project is intended to be a safe, welcoming space for collaboration, and contributors are expected to adhere to the [code of conduct](https://github.com/hebron-george/open_fda_api/blob/main/CODE_OF_CONDUCT.md).
120
154
121
155
## License
122
156
123
157
The gem is available as open source under the terms of the [MIT License](https://opensource.org/licenses/MIT).
124
158
125
159
## Code of Conduct
126
160
127
-
Everyone interacting in the OpenFdaApi project's codebases, issue trackers, chat rooms and mailing lists is expected to follow the [code of conduct](https://github.com/[USERNAME]/open_fda_api/blob/master/CODE_OF_CONDUCT.md).
161
+
Everyone interacting in the OpenFdaApi project's codebases, issue trackers, chat rooms and mailing lists is expected to follow the [code of conduct](https://github.com/hebron-george/open_fda_api/blob/main/CODE_OF_CONDUCT.md).
"disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
4
+
"terms": "https://open.fda.gov/terms/",
5
+
"license": "https://open.fda.gov/license/",
6
+
"last_updated": "2024-01-01",
7
+
"results": {
8
+
"skip": 0,
9
+
"limit": 1,
10
+
"total": 100
11
+
}
12
+
},
13
+
"results": [
14
+
{
15
+
"file_name": "example_crl.pdf",
16
+
"application_number": "NDA012345",
17
+
"letter_type": "COMPLETE RESPONSE",
18
+
"letter_date": "2023-06-15",
19
+
"company_name": "Example Pharmaceuticals Inc.",
20
+
"company_rep": "Jane Smith",
21
+
"company_address": "123 Pharma Way, New York, NY 10001",
22
+
"approver_name": "John Doe",
23
+
"approver_title": "Acting Deputy Director",
24
+
"approver_center": "Center for Drug Evaluation and Research",
25
+
"text": "We have completed our review of this application and have determined that we cannot approve this application in its present form."
0 commit comments